A vision statement on guideline development for respiratory disease: the example of COPD

The Lancet

Volumn 373, Issue 9665, 2009, Pages 774-779

  Schünemann, Holger J ^a,b,c   Woodhead, Mark ^d   Anzueto, Antonio ^e   Buist, Sonia ^f   MacNee, William ^g   Rabe, Klaus F ^h   Heffner, John ^f  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY AT BUFFALO   (United States)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^g UNIVERSITY OF EDINBURGH   (United Kingdom)

^h LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; COMORBIDITY; CONFLICT OF INTEREST; DATA BASE; DECISION MAKING; HEALTH CARE SYSTEM; HUMAN; ORGANIZATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SOCIETY; STANDARDIZATION; TECHNOLOGY; WORLD HEALTH ORGANIZATION;

EID: 60649090174     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61347-1     Document Type: Note

References (11)

1. Bradbury J. Storm over WHO-ISH hypertension guidelines. Lancet 353 (1999) 563
2. Grilli R., Magrini N., Penna A., Mura G., and Liberati A. Practice guidelines developed by specialty societies: the need for a critical appraisal. Lancet 355 (2000) 103-106
3. Horton R. WHO: the casualties and compromises of renewal. Lancet 359 (2002) 1605-1611
4. Oxman A.D., Fretheim A., and Schunemann H.J. Improving the use of research evidence in guideline development: introduction. Health Res Policy Syst 4 (2006) 12
5. Schünemann H.J., Jaeschke R., Cook D.J., et al. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med 174 (2006) 605-614
6. Schünemann H.J., Hill S.R., Kakad M., et al. WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus. Lancet Infect Dis 7 (2007) 21-31
7. Schünemann H, Oxman AD, Vist GE, et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions, 2008. http://www.cochrane-handbook.org (accessed June 30, 2008).
8. Guyatt G., Gutterman D., Baumann M.H., et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American college of chest physicians task force. Chest 129 (2006) 174-181
9. Guyatt G.H., Oxman A.D., Vist G.E., et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336 (2008) 924-926
10. Glasziou P., and Haynes B. The paths from research to improved health outcomes. Evid Based Nurs 8 (2005) 36-38
11. Oxman A.D., Lavis J.N., and Fretheim A. Use of evidence in WHO recommendations. Lancet 369 (2007) 1883-1889